Research examines brain locations that control diabetes drugs' weight loss effects

(Sanford-Burnham Prebys Medical Discovery Institute) Certain type 2 diabetes drugs promote weight loss. Insight into how these drugs work could help create new drugs that effectively control weight. In an important advance on that front, a new study from Sanford Burnham Prebys Medical Discovery Institute shows that these drugs, called glucagon-like peptide-1 receptor agonists, reduce body mass by targeting a different part of the brain than previously thought.